Selenium in Graves' disease
The aim of this study was to present the current state of knowledge of the role of selenium in Graves' disease. Recently, in the pathogenesis and course of this autoimmune disease, more attention has been paid to the relationship between oxidative stress and the antioxidant system, where selenium compounds play an important role. The thyroid is the organ with the highest selenium concentration in the human body. Selenium compounds, having antioxidant properties, protect thyrocytes against the destructive effects of reactive oxygen species (ROS), which are generated during the synthesis of thyroid hormones. Therefore, strengthening the body's defense mechanisms, which protect against the formation and activity of ROS during medical treatment of Graves' disease patients, may be an effective adjuvant in commonly used methods of therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
|---|---|
| Enthalten in: |
Postepy higieny i medycyny doswiadczalnej (Online) - 67(2013) vom: 24. Mai, Seite 491-8 |
| Sprache: |
Polnisch |
|---|
| Weiterer Titel: |
Selen w chorobie Gravesa-Basedowa |
|---|
| Beteiligte Personen: |
Kryczyk, Jadwiga [VerfasserIn] |
|---|
| Themen: |
Antioxidants |
|---|
| Anmerkungen: |
Date Completed 11.09.2013 Date Revised 12.11.2019 published: Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM228217849 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM228217849 | ||
| 003 | DE-627 | ||
| 005 | 20231224075417.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||pol c | ||
| 028 | 5 | 2 | |a pubmed24n0760.xml |
| 035 | |a (DE-627)NLM228217849 | ||
| 035 | |a (NLM)23752601 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a pol | ||
| 100 | 1 | |a Kryczyk, Jadwiga |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Selenium in Graves' disease |
| 246 | 3 | 3 | |a Selen w chorobie Gravesa-Basedowa |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.09.2013 | ||
| 500 | |a Date Revised 12.11.2019 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The aim of this study was to present the current state of knowledge of the role of selenium in Graves' disease. Recently, in the pathogenesis and course of this autoimmune disease, more attention has been paid to the relationship between oxidative stress and the antioxidant system, where selenium compounds play an important role. The thyroid is the organ with the highest selenium concentration in the human body. Selenium compounds, having antioxidant properties, protect thyrocytes against the destructive effects of reactive oxygen species (ROS), which are generated during the synthesis of thyroid hormones. Therefore, strengthening the body's defense mechanisms, which protect against the formation and activity of ROS during medical treatment of Graves' disease patients, may be an effective adjuvant in commonly used methods of therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Antioxidants |2 NLM | |
| 650 | 7 | |a Reactive Oxygen Species |2 NLM | |
| 650 | 7 | |a Thyroid Hormones |2 NLM | |
| 650 | 7 | |a Selenium |2 NLM | |
| 650 | 7 | |a H6241UJ22B |2 NLM | |
| 700 | 1 | |a Zagrodzki, Paweł |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Postepy higieny i medycyny doswiadczalnej (Online) |d 2004 |g 67(2013) vom: 24. Mai, Seite 491-8 |w (DE-627)NLM147657105 |x 1732-2693 |7 nnns |
| 773 | 1 | 8 | |g volume:67 |g year:2013 |g day:24 |g month:05 |g pages:491-8 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 67 |j 2013 |b 24 |c 05 |h 491-8 | ||